Meanwhile, the UK launch of Freestyle Libre 3 comes as rival real-time CGM player Dexcom received a European CE mark for its G7 device for people with diabetes aged two years and older.

Both stocks should deliver excellent returns to investors patient enough to hold through volatility. Equity markets started ...

Investors with a lot of money to spend have taken a bullish stance on DexCom (NASDAQ:DXCM). And retail traders should know. We noticed this today when the positions showed up on publicly available ...

Dexcom, a medical device manufacturer that develops continuous glucose monitoring systems, received a warning letter from the FDA regarding manufacturing processes at its facilities in San Diego ...

Connacht and Munster lock horns this weekend as the United Rugby Championship season yields another tantalising interprovincial derby.

Over the past six months, DexCom has been a great trade. While the S&P 500 was flat, the stock price has climbed by 8% to $74.17 per share. This run-up might have investors contemplating their ...

There were impressive scenes as the Red Arrows made the transit from their home unit of RAF Waddington in Lincolnshire to RAF Lossiemouth in Scotland on Monday. The team will spend a week in the ...

Most CGMs require a prescription. However, the FDA recently cleared the first over-the-counter CGM for purchase without a prescription, the Dexcom Stelo. If you get one, Eckman says you should ...

Let’s take a look at how patient monitoring stocks fared in Q4, starting with DexCom (NASDAQ:DXCM). Patient monitoring companies within the healthcare equipment industry offer devices and ...

THERMAL, Calif. — After sweeping the front row spots for the second INDYCAR race of the season, Arrow McLaren driver Christian Lundgaard quipped: "We're just trying to copy what they do in ...